Tandem Diabetes Care, Inc. (TNDM)
NASDAQ: TNDM · Real-Time Price · USD
15.30
-0.10 (-0.65%)
At close: Jun 18, 2026, 4:00 PM EDT
15.60
+0.30 (1.96%)
After-hours: Jun 18, 2026, 7:39 PM EDT
Tandem Diabetes Care Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 179.33 | 90.63 | 69.23 | 58.87 | 172.52 | 71.18 |
Short-Term Investments | 390.93 | 202.03 | 369.1 | 409.04 | 444.38 | 552.63 |
Cash & Short-Term Investments | 570.26 | 292.67 | 438.33 | 467.91 | 616.9 | 623.81 |
Cash Growth | 54.70% | -33.23% | -6.32% | -24.15% | -1.11% | 28.64% |
Accounts Receivable | 140.67 | 165.49 | 114.59 | 105.56 | 114.72 | 110.73 |
Inventory | 126.4 | 128.77 | 149.61 | 157.94 | 111.12 | 68.55 |
Other Current Assets | 49.77 | 31.22 | 21.97 | 16.59 | 7.24 | 8.43 |
Total Current Assets | 887.1 | 618.14 | 724.49 | 747.99 | 849.98 | 811.52 |
Net Property, Plant & Equipment | 178.99 | 179.75 | 163.46 | 164.33 | 179.18 | 77.89 |
Long-Term Investments | 56.49 | 60.35 | 74.55 | 40.34 | - | - |
Other Long-Term Assets | 30.82 | 22.87 | 5.17 | - | 23.63 | 15.73 |
Total Assets | 1,153 | 881.11 | 967.66 | 952.66 | 1,053 | 905.14 |
Accounts Payable | 59.86 | 47.07 | 44.73 | 49.59 | 55.73 | 28.03 |
Accrued Expenses | 74.93 | 91.42 | 82.3 | 56.16 | 48.28 | 60.98 |
Current Portion of Long-Term Debt | - | - | 40.67 | - | - | - |
Current Portion of Leases | 20.11 | 19.47 | 18.21 | 17.06 | 13.12 | 9.28 |
Unearned Revenue | 8.95 | 9.53 | 11.83 | 43.99 | 18.84 | 10.18 |
Other Current Liabilities | 84.1 | 75.24 | 49.31 | 28.46 | 29.33 | 23.39 |
Total Current Liabilities | 247.96 | 242.72 | 247.05 | 195.26 | 165.29 | 131.86 |
Long-Term Debt | 601.77 | 310.04 | 308.27 | 285.04 | 283.23 | 281.47 |
Long-Term Leases | 112.86 | 114.97 | 106.42 | 113.57 | 123.52 | 23.92 |
Other Long-Term Liabilities | 58.41 | 58.22 | 42.82 | 45.16 | 40.79 | 34.78 |
Total Long-Term Liabilities | 773.03 | 483.22 | 457.51 | 443.77 | 447.55 | 340.17 |
Total Liabilities | 1,021 | 725.94 | 704.56 | 639.03 | 612.84 | 472.03 |
Common Stock | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 | 0 |
Additional Paid-in Capital | 1,400 | 1,402 | 1,313 | 1,264 | 1,171 | 1,068 |
Accumulated Other Comprehensive Income | 5.04 | 5.59 | -1.95 | 1.37 | -1.82 | -0.62 |
Retained Earnings | -1,273 | -1,253 | -1,048 | -951.8 | -729.19 | -634.6 |
Shareholders' Equity | 132.4 | 155.17 | 263.1 | 313.63 | 439.95 | 433.11 |
Total Liabilities & Equity | 1,153 | 881.11 | 967.66 | 952.66 | 1,053 | 905.14 |
Total Debt | 734.74 | 444.48 | 473.57 | 415.67 | 419.88 | 314.67 |
Net Cash (Debt) | -164.48 | -151.81 | -35.24 | 52.25 | 197.02 | 309.14 |
Net Cash Growth | - | - | - | -73.48% | -36.27% | 20.47% |
Net Cash Per Share | -2.43 | -2.26 | -0.54 | 0.80 | 3.07 | 4.80 |
Book Value | 132.4 | 155.17 | 263.1 | 313.63 | 439.95 | 433.11 |
Book Value Per Share | 1.95 | 2.31 | 4.02 | 4.83 | 6.86 | 6.73 |
Tangible Book Value | 132.4 | 155.17 | 263.1 | 313.63 | 439.95 | 433.11 |
Tangible Book Value Per Share | 1.95 | 2.31 | 4.02 | 4.83 | 6.86 | 6.73 |